Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript

So that triggers the program nomination that takes away from those opportunities that they have. And so all I can say is we’ve met that validation criteria on that translation. And the key now is really thinking about these are therapeutics that drive towards the clinic. So if we think about therapeutic again — this is across modalities. We’re doing this work. And so there’s a lot of ongoing work. Then I think holistically we really benefit from. So if you think about why we did this part of the collaboration, there is a lot of research and discovery efforts that we’re doing across these various targets that are informing us in our strategy as we think about the pipeline creation at Wave.

Operator: Thank you. I’m not showing any further questions at this time. I’d like to turn the call back over to Paul for any closing remarks.

Paul Bolno: Thank you, operator. Thank you all for joining the call this morning. We’re excited to see many of you in New York with RBC Capital next week and we look forward to keeping you all updated on our progress. Have a great day.

Operator: Ladies and gentlemen, that concludes today presentation. You may now disconnect, and have a wonderful day.